137 related articles for article (PubMed ID: 37648878)
1. Survival outcomes of anal adenocarcinoma versus rectal adenocarcinoma: A retrospective cohort study.
Mankarious MM; Hughes AJ; Berg AS; Scow JS; Jeganathan AN; Kulaylat AS; Deutsch MJ
Indian J Gastroenterol; 2023 Oct; 42(5):694-700. PubMed ID: 37648878
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Anal Versus Rectal Staging in the Prognostication of Rectal Squamous Cell Carcinoma: A Population-Based Analysis.
Goffredo P; Robinson TJ; Frakes JM; Utria AF; Scott AT; Hassan I
Dis Colon Rectum; 2019 Mar; 62(3):302-308. PubMed ID: 30398999
[TBL] [Abstract][Full Text] [Related]
3. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes after surgical dissection of inguinal lymph node metastasis from rectal or anal canal adenocarcinoma.
Tanabe T; Shida D; Komukai S; Nakamura Y; Tsukamoto S; Kanemitsu Y
BMC Cancer; 2019 Jul; 19(1):733. PubMed ID: 31340778
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
6. Squamous Cancers of the Rectum Demonstrate Poorer Survival and Increased Need for Salvage Surgery Compared With Squamous Cancers of the Anus.
Kulaylat AS; Hollenbeak CS; Stewart DB
Dis Colon Rectum; 2017 Sep; 60(9):922-927. PubMed ID: 28796730
[TBL] [Abstract][Full Text] [Related]
7. What factors are associated with the poor prognosis of anal adenocarcinoma compared with low-lying rectal adenocarcinoma based on a population analysis: A propensity score matching study.
Wang Q; Fu J; Chen X; Cai C; Ruan H; Du J
PLoS One; 2019; 14(7):e0219937. PubMed ID: 31361759
[TBL] [Abstract][Full Text] [Related]
8. Anal adenocarcinoma: Treatment outcomes and trends in a rare disease entity.
Wegner RE; White RJ; Hasan S; Raj M; Monga D; Finley G; Kirichenko AV; McCormick J
Cancer Med; 2019 Jul; 8(8):3855-3863. PubMed ID: 31173487
[TBL] [Abstract][Full Text] [Related]
9. Survival Outcomes After Initial Treatment for Anal Adenocarcinoma: A Population-Based Cohort Study.
Park H
Clin Colorectal Cancer; 2020 Sep; 19(3):e75-e82. PubMed ID: 32389595
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes and Patterns of Management for Anal Adenocarcinoma.
Lewis GD; Haque W; Butler EB; Teh BS
Ann Surg Oncol; 2019 May; 26(5):1351-1357. PubMed ID: 30719638
[TBL] [Abstract][Full Text] [Related]
11. Characteristics, treatment, and outcomes of anal versus rectal squamous cell carcinoma, a retrospective cohort study.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Strassmann V; Wexner SD
Surgery; 2023 Sep; 174(3):508-516. PubMed ID: 37380571
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
[TBL] [Abstract][Full Text] [Related]
13. Local excision and chemoradiation for clinical node-negative anal adenocarcinoma.
Chatani PD; Dominguez DA; Aversa JG; Davis JL; Hernandez JM; Lai LL; Blakely AM
Surg Oncol; 2021 Jun; 37():101551. PubMed ID: 33819849
[TBL] [Abstract][Full Text] [Related]
14. Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection After Neoadjuvant Chemoradiation for Initial cT3 Juxta-Anal Rectal Cancer.
Huang S; Huang Y; Chi P; Lin H; Lu X; Xu Z; Sun Y; Wang X
J Laparoendosc Adv Surg Tech A; 2019 Jun; 29(6):809-816. PubMed ID: 30596539
[No Abstract] [Full Text] [Related]
15. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
[TBL] [Abstract][Full Text] [Related]
16. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Klas JV; Rothenberger DA; Wong WD; Madoff RD
Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
[TBL] [Abstract][Full Text] [Related]
17. A twenty-year experience with adenocarcinoma of the anal canal.
Chang GJ; Gonzalez RJ; Skibber JM; Eng C; Das P; Rodriguez-Bigas MA
Dis Colon Rectum; 2009 Aug; 52(8):1375-80. PubMed ID: 19617747
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes after local excision and radical surgery for anal melanoma: data from a population database.
Kiran RP; Rottoli M; Pokala N; Fazio VW
Dis Colon Rectum; 2010 Apr; 53(4):402-8. PubMed ID: 20305438
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
20. Tumor deposits in rectal adenocarcinoma after neoadjuvant chemoradiation are associated with poor prognosis.
Gopal P; Lu P; Ayers GD; Herline AJ; Washington MK
Mod Pathol; 2014 Sep; 27(9):1281-7. PubMed ID: 24434897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
